Showing results (371-380 of 414) with videos related to

Sort By:
Pageof 42
Bioorganic & Medicinal Chemistry Letters|March 8, 2008
The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Global Health, Epidemiology and Genomics|June 6, 2018
Strengthening human genetics research in Africa: report of the 9th meeting of the African Society of Human Genetics in Dakar in May 2016R Ndiaye Diallo, M Gadji, B J Hennig, et al.
Global Health, Epidemiology and Genomics|June 6, 2018
The need for an integrated approach for chronic disease research and care in AfricaA L Barr, E H Young, L Smeeth, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric siteAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Journal of Medicinal Chemistry|May 30, 2020
Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA HelicaseJustin T Ernst, Peggy A Thompson, Christian Nilewski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Using Traveler-based Genomic Surveillance at 4 US Airports, September 2021-January 2022Renee D Wegrzyn, Grace D Appiah, Robert Morfino, et al.
Molecular Cancer Therapeutics|October 10, 2020
Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4APeggy A Thompson, Boreth Eam, Nathan P Young, et al.
Pageof 42